Alla / NASDAQ / Capricor Therapeutics

Capricor Therapeutics

Capricor Therapeutics

Investera provisionsfritt

Köp och sälj delar av aktier för så lite som 1 €

Info och statistik

Dagens utbud
1 d−100,00 %
3 m−100,00 %
1 v−100,00 %
6 m−100,00 %
1 m−100,00 %
1 å−100,00 %
SYMBOL
CAPR
MARKNAD
NASDAQ
ISIN
US14070B3096

Datum

Stängnings

Förändring

Förändring (%)

Öppnings

Högt

Lågt

7,59−0,57−7,51 %8,168,347,37
7,53−0,50−6,64 %8,039,107,38
8,03−0,75−9,34 %8,789,497,99
8,41−0,30−3,57 %8,718,988,23
8,30−0,91−10,96 %9,219,358,19
9,53−0,68−7,14 %10,2110,219,25
10,24−0,71−6,93 %10,9510,959,87
11,221,3712,21 %9,8511,239,01
8,87−0,78−8,79 %9,6510,068,85
9,850,717,21 %9,1410,008,55
9,000,293,22 %8,719,118,30
8,60−0,04−0,47 %8,648,698,15
8,920,738,18 %8,198,947,90
8,241,0112,26 %7,238,327,15
7,240,364,97 %6,887,456,67
6,38−0,20−3,13 %6,586,646,14
6,630,395,88 %6,246,936,24
6,230,233,69 %6,006,405,90
6,100,355,74 %5,756,315,67
5,74−0,17−2,96 %5,915,955,68
5,93−0,10−1,69 %6,036,085,80
6,130,335,38 %5,806,355,80
5,88−0,72−12,24 %6,606,755,79
6,610,081,21 %6,536,836,47
6,65−0,16−2,41 %6,816,926,54
6,71−0,50−7,45 %7,217,256,68
7,270,638,67 %6,647,336,64
6,59−0,17−2,58 %6,766,886,47
6,88−0,38−5,52 %7,267,396,87
7,47−0,32−4,28 %7,797,807,45
7,83−0,22−2,81 %8,058,057,69
8,010,121,5 %7,898,177,80
8,100,516,3 %7,598,257,46
7,750,030,39 %7,727,897,47
7,78−1,01−12,98 %8,798,797,37
8,95−0,09−1,01 %9,049,248,77
8,94−0,38−4,25 %9,329,398,84
9,47−0,56−5,91 %10,0310,709,40
8,57−0,14−1,63 %8,718,968,51
8,710,424,82 %8,298,838,15
8,36−0,25−2,99 %8,618,678,30
8,57−0,03−0,35 %8,608,868,27
8,67−0,59−6,81 %9,269,328,53
9,340,293,1 %9,059,488,89
8,90−0,21−2,36 %9,119,278,84
9,06−0,21−2,32 %9,279,358,96
9,420,495,2 %8,939,798,84
8,56−0,01−0,12 %8,579,078,41
8,56−0,27−3,15 %8,838,908,37
8,81−0,38−4,31 %9,199,248,71
8,370,050,6 %8,328,678,26
8,30−0,26−3,13 %8,568,708,18
8,64−0,42−4,86 %9,069,268,61
9,06−0,09−0,99 %9,159,488,81
9,400,000 %9,409,809,26
9,28−0,55−5,93 %9,839,939,14
9,89−0,17−1,72 %10,0610,659,60
10,01−0,76−7,59 %10,7710,999,85
9,910,505,05 %9,4110,249,07
9,59−0,14−1,46 %9,7310,199,47
10,060,888,75 %9,1810,618,90
9,361,1312,07 %8,239,888,05
8,291,0212,3 %7,278,597,27
6,80−1,21−17,79 %8,018,016,34
6,29−0,51−8,11 %6,807,086,01
6,83−0,83−12,15 %7,667,806,83
7,980,8110,15 %7,177,997,15
7,08−0,42−5,93 %7,508,286,76
7,450,577,65 %6,887,596,59
6,65−1,03−15,49 %7,688,146,05
4,21−0,01−0,24 %4,224,424,14
4,190,266,21 %3,934,303,90
3,930,082,04 %3,853,993,73
3,85−0,18−4,68 %4,034,103,80
4,09−0,07−1,71 %4,164,704,05
4,180,307,18 %3,884,213,88
3,93−0,24−6,11 %4,174,313,84
4,170,040,96 %4,134,424,09
4,200,4310,24 %3,774,203,66
3,85−0,20−5,19 %4,054,663,80
4,191,1226,73 %3,074,212,96
6,57−0,21−3,2 %6,787,215,70
6,991,1716,74 %5,827,835,82
19,70−0,01−0,05 %19,7120,1718,30
19,831,316,61 %18,5220,5418,50
18,91−0,81−4,28 %19,7219,9218,76
19,790,291,47 %19,5020,1618,97
19,50−0,18−0,92 %19,6820,1719,00
19,440,673,45 %18,7719,7918,65
19,12−1,27−6,64 %20,3920,4919,00
20,35−0,28−1,38 %20,6320,7619,60
20,680,090,44 %20,5921,0420,27
20,61−0,66−3,2 %21,2721,3820,17
21,51−1,07−4,97 %22,5822,5821,19
22,500,070,31 %22,4322,5221,76
22,25−0,01−0,04 %22,2623,0321,41
22,22−0,32−1,44 %22,5422,7021,82
22,43−1,14−5,08 %23,5723,8521,64
23,21−0,04−0,17 %23,2524,5622,54
23,07−0,98−4,25 %24,0524,2523,04
24,080,220,91 %23,8624,9923,86
23,80−3,21−13,49 %27,0127,0323,49
26,44−0,57−2,16 %27,0127,4025,66
30,401,003,29 %29,4030,9329,29
29,51−0,37−1,25 %29,8829,9929,19
29,600,872,94 %28,7329,9928,53
29,34−0,16−0,55 %29,5030,1928,89
28,380,100,35 %28,2829,2227,65
27,950,672,4 %27,2828,7026,97
26,05−0,79−3,03 %26,8427,0325,60
26,720,682,54 %26,0426,9626,00
25,800,682,64 %25,1226,1225,02
25,04−0,32−1,28 %25,3625,6424,65
25,33−0,67−2,65 %26,0026,4225,01
26,01−0,54−2,08 %26,5526,9725,07
26,16−0,99−3,78 %27,1527,3826,00
26,71−1,17−4,38 %27,8827,9526,56
27,950,180,64 %27,7728,4627,51
27,640,612,21 %27,0327,8626,92
27,34−0,71−2,6 %28,0528,2627,09
28,53−0,99−3,47 %29,5229,5228,03
29,96−0,03−0,1 %29,9930,5029,54
29,11−0,10−0,34 %29,2129,3628,77
29,14−0,28−0,96 %29,4229,8728,89
29,36−0,07−0,24 %29,4329,4528,85
28,87−0,71−2,46 %29,5829,9328,66
29,580,822,77 %28,7629,9228,17
29,011,495,14 %27,5229,1227,08
26,92−1,08−4,01 %28,0028,0026,60
28,01−0,98−3,5 %28,9929,1927,38
28,79−0,32−1,11 %29,1129,8328,53
29,81−0,69−2,31 %30,5030,9229,37
30,33−0,17−0,56 %30,5031,9429,26
31,52−0,06−0,19 %31,5832,0530,92
31,901,605,02 %30,3032,5530,02
30,380,882,9 %29,5031,2728,50
33,94−0,01−0,03 %33,9534,2633,02
34,381,243,61 %33,1434,5032,88
32,96−0,74−2,25 %33,7034,3431,58
33,502,296,84 %31,2133,6431,06
30,91−2,59−8,38 %33,5033,5930,85
33,580,521,55 %33,0634,6432,74
32,46−1,44−4,44 %33,9034,1132,31
33,98−1,02−3 %35,0035,8533,62
35,10−0,20−0,57 %35,3035,4534,13
35,271,403,97 %33,8735,3433,06
33,86−1,14−3,37 %35,0035,0732,86
35,00−0,61−1,74 %35,6135,9934,53
35,340,982,77 %34,3635,4733,76
34,21−0,46−1,34 %34,6736,8233,90
34,70−0,66−1,9 %35,3635,6634,35
34,59−0,70−2,02 %35,2935,3733,44
35,040,220,63 %34,8235,3034,07
34,720,712,04 %34,0134,7733,38
34,543,339,64 %31,2135,9930,90
31,20−0,34−1,09 %31,5431,6829,58
31,610,391,23 %31,2232,1330,98
31,60−1,27−4,02 %32,8733,0031,29
31,970,601,88 %31,3731,9830,33
31,68−0,30−0,95 %31,9833,1431,40
32,113,029,41 %29,0932,3928,91
30,12−0,33−1,1 %30,4531,7429,95
30,401,886,18 %28,5230,4728,29
27,77−1,15−4,14 %28,9229,2727,50
28,90−0,72−2,49 %29,6230,4528,37
29,950,511,7 %29,4430,2429,09
29,900,722,41 %29,1830,4429,04
28,87−0,73−2,53 %29,6029,9128,39
30,100,431,43 %29,6730,3228,15
29,10−2,12−7,29 %31,2232,4529,10
31,170,732,34 %30,4431,2529,40
30,90−0,35−1,13 %31,2531,5030,41
31,190,541,73 %30,6531,8430,14
30,560,040,13 %30,5232,4430,19
30,50−2,50−8,2 %33,0033,0029,40
33,42−0,52−1,56 %33,9434,2132,25
33,571,073,19 %32,5035,0832,50
33,400,902,69 %32,5036,4932,08
30,63−0,18−0,59 %30,8131,4028,99
27,902,498,92 %25,4128,8825,07
25,820,321,24 %25,5025,8625,10
25,50−0,94−3,69 %26,4426,5825,34
25,840,210,81 %25,6326,5225,12
26,860,170,63 %26,6927,5526,30
27,930,200,72 %27,7327,9827,13
27,89−0,51−1,83 %28,4028,4527,45
28,350,361,27 %27,9928,8527,90
27,910,260,93 %27,6528,0327,06
27,87−0,28−1 %28,1529,0827,36
28,51−0,19−0,67 %28,7029,4027,54
29,153,6812,62 %25,4729,2325,07
25,532,549,95 %22,9926,1522,80
23,030,542,34 %22,4923,3422,05
22,45−1,79−7,97 %24,2424,3622,27
23,67−0,33−1,39 %24,0024,4823,23
24,20−0,57−2,36 %24,7725,0823,81
24,63−0,44−1,79 %25,0725,4524,49
25,190,471,87 %24,7225,3124,30
24,721,365,5 %23,3625,2123,23
23,03−1,66−7,21 %24,6924,8022,71
24,50−0,28−1,14 %24,7824,7923,70
24,881,837,36 %23,0524,9222,81
23,091,325,72 %21,7723,0921,75
21,89−0,81−3,7 %22,7023,0021,83
22,611,014,47 %21,6022,7021,06
21,57−2,29−10,62 %23,8623,8621,43
23,52−0,17−0,72 %23,6923,7223,10
23,620,612,58 %23,0123,6822,80
23,20−0,82−3,53 %24,0224,1423,01
24,17−0,17−0,7 %24,3424,7424,08
24,310,451,85 %23,8624,6023,52
24,20−0,91−3,76 %25,1125,7023,58
24,350,190,78 %24,1624,8823,96
24,04−0,64−2,66 %24,6824,6823,53
24,790,281,13 %24,5125,0024,23
24,790,522,1 %24,2725,4424,12
24,511,044,24 %23,4724,8623,24
23,84−2,36−9,9 %26,2026,2023,15
25,55−0,31−1,21 %25,8626,2225,07
26,310,230,87 %26,0826,9325,70
26,131,405,36 %24,7326,4424,66
24,81−3,13−12,62 %27,9428,4924,35
28,31−0,67−2,37 %28,9829,3627,52
28,860,100,35 %28,7629,2428,01
28,96−1,04−3,59 %30,0030,0928,21
30,040,411,36 %29,6330,7129,59
29,690,160,54 %29,5329,9029,20
29,680,792,66 %28,8930,1228,51
28,90−0,18−0,62 %29,0829,7428,59
29,501,575,32 %27,9329,9827,78
27,811,605,75 %26,2129,4426,11
26,190,080,31 %26,1126,9926,04
26,150,311,19 %25,8426,8525,60
26,02−0,03−0,12 %26,0526,7125,78
26,550,652,45 %25,9027,1725,87
26,02−0,53−2,04 %26,5527,0725,59
27,18−0,81−2,98 %27,9928,4727,15
28,670,682,37 %27,9929,2327,51
27,38−0,62−2,26 %28,0028,3427,02
28,561,946,79 %26,6231,4426,24
26,890,170,63 %26,7228,6226,01
25,40−2,99−11,77 %28,3930,5823,05
29,96−0,04−0,13 %30,0040,3721,50
6,36−0,39−6,13 %6,756,786,15
6,651,3019,55 %5,357,155,35
5,350,091,68 %5,265,925,22
5,190,5410,4 %4,655,204,63
4,600,153,26 %4,454,844,30
4,64−0,94−20,26 %5,585,614,40
5,750,122,09 %5,636,005,51
5,69−0,13−2,28 %5,826,015,67
5,770,091,56 %5,685,895,60
5,640,081,42 %5,565,775,54
5,690,091,58 %5,605,995,53
5,600,000 %5,605,825,53
5,77−0,06−1,04 %5,836,035,71
5,87−0,31−5,28 %6,186,545,85
6,200,304,84 %5,906,395,66
5,56−0,44−7,91 %6,006,275,43
5,93−0,35−5,9 %6,286,335,90
6,280,000 %6,286,416,15
6,220,162,57 %6,066,266,03
6,060,010,17 %6,056,416,01
6,07−0,38−6,26 %6,456,466,06
6,510,162,46 %6,356,546,17
6,21−0,55−8,86 %6,766,836,19
6,920,7410,69 %6,187,086,12
6,180,000 %6,186,316,12
6,18−0,02−0,32 %6,206,416,17
6,200,040,65 %6,166,336,05
6,13−0,06−0,98 %6,196,286,11
6,23−0,12−1,93 %6,356,376,10
6,37−0,05−0,78 %6,426,496,32
6,400,071,09 %6,336,566,29
6,250,101,6 %6,156,546,01
6,16−0,59−9,58 %6,756,826,13
6,69−0,03−0,45 %6,726,886,62
6,700,081,19 %6,626,806,46
6,72−0,41−6,1 %7,137,156,70
7,09−0,53−7,48 %7,627,627,06
7,620,111,44 %7,517,817,48
7,48−0,05−0,67 %7,537,707,45
7,50−0,30−4 %7,807,807,44
7,810,536,79 %7,287,877,24
7,36−0,57−7,74 %7,937,937,24
7,97−0,03−0,38 %8,008,067,64
7,820,617,8 %7,217,887,21
7,21−0,20−2,77 %7,417,637,11
7,410,202,7 %7,217,637,16
7,090,689,59 %6,417,276,35
6,52−0,29−4,45 %6,817,326,43
6,190,030,48 %6,166,286,05
6,150,091,46 %6,066,316,06
6,09−0,51−8,37 %6,606,606,08
6,650,223,31 %6,436,666,29
6,400,172,66 %6,236,496,16
6,08−0,13−2,14 %6,216,276,04
6,220,010,16 %6,216,386,11
6,04−0,39−6,46 %6,436,575,98
6,36−0,11−1,73 %6,476,476,27
6,440,335,12 %6,116,526,04
6,33−0,21−3,32 %6,546,616,31
6,480,101,54 %6,386,526,14
6,35−0,28−4,41 %6,636,766,33
6,740,7410,98 %6,006,765,81
5,94−0,38−6,4 %6,326,325,68
6,28−0,03−0,48 %6,316,436,23
6,330,071,11 %6,266,406,19
6,280,000 %6,286,366,18
6,26−0,05−0,8 %6,316,436,17
6,25−0,08−1,28 %6,336,546,20
6,47−0,08−1,24 %6,556,606,30
6,60−0,50−7,58 %7,107,106,50
7,100,081,13 %7,027,296,93
7,01−0,10−1,43 %7,117,236,94
7,17−0,48−6,69 %7,657,676,90
7,67−0,09−1,17 %7,767,997,60
7,70−0,15−1,95 %7,857,997,68
7,960,293,64 %7,677,987,59
7,78−0,45−5,78 %8,238,307,75
8,300,232,77 %8,078,607,92
8,040,222,74 %7,828,087,60
7,81−0,37−4,74 %8,188,337,77
9,071,1612,79 %7,919,437,91
8,070,263,22 %7,818,077,54
7,740,070,9 %7,677,827,52
7,670,000 %7,677,797,35
7,68−0,13−1,69 %7,817,907,20
7,90−0,03−0,38 %7,938,287,72
8,180,182,2 %8,008,557,77
8,180,354,28 %7,838,487,51
6,74−0,29−4,3 %7,037,106,61
6,79−0,23−3,39 %7,027,286,72
7,060,456,37 %6,617,086,43
6,48−0,32−4,94 %6,806,806,29
6,820,192,79 %6,637,076,48
6,520,243,68 %6,286,786,24
6,27−0,63−10,05 %6,906,966,19
6,88−0,28−4,07 %7,167,276,88
7,16−0,09−1,26 %7,257,456,97
7,240,070,97 %7,177,436,83
7,17−0,20−2,79 %7,377,466,95
7,38−0,06−0,81 %7,447,496,85
7,640,658,51 %6,998,636,75
11,40−0,02−0,18 %11,4211,5310,62
11,420,968,41 %10,4611,8710,34
10,170,191,87 %9,9810,299,87
9,900,000 %9,9010,109,65
10,250,111,07 %10,1410,5610,11
10,020,353,49 %9,6710,109,45
9,700,010,1 %9,6910,029,48
9,93−1,22−12,29 %11,1511,199,88
11,150,908,07 %10,2511,5710,00
10,18−0,15−1,47 %10,3310,509,80
10,050,818,06 %9,2410,478,91
9,251,3514,59 %7,909,357,83
7,68−0,32−4,17 %8,008,026,93
8,26−3,13−37,89 %11,3911,466,07
11,94−0,09−0,75 %12,0312,6211,86
12,190,171,39 %12,0213,5011,58
12,380,272,18 %12,1112,4211,75
11,78−1,89−16,04 %13,6713,8011,76
13,940,966,89 %12,9813,9712,67
13,14−1,04−7,91 %14,1814,2612,30
13,890,594,25 %13,3014,2113,05

Liknande diskussioner

MarkyBoy212

för 5 dagar sedan

Big Week, good luck everyone

I am still very on the fence on this since the Adcom. I hope we all make money when the decision arrives

MarkyBoy212

förra veckan

A new buy rating and 2 maintained buys very nice

A new buy rating and 2 maintained buys very nice, hoping this gets approval after earnings and award

ByronKS

förra veckan

Capricor earnings report

See the Capricor Therapeutics earnings report below. Good luck! 🤞🏼🍀 https://web.quartr.com/link/companies/5913/events/732825/report?rp=0&documentId=4012432

MarkyBoy212

för 2 veckor sedan

Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology

Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology

TerraNova23

för 2 veckor sedan

Anyone else think this will fail?

According to Adam Feuerstein, Capricor faces two major risks: Weak Clinical Evidence: The FDA may consider Deramiocel's efficacy data insufficient for approval. Public Pressure on the FDA: Capricor's public statements could suggest concerns about its chances of approval. And there is still the 3-9 vote from before.

MarkyBoy212

för 2 månader sedan

Will be good to have data out

Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress

Prayers

för 3 månader sedan

This too (and yh I DO wish I did this in CFD lol)

This too (and yh I DO wish I did this in CFD lol)

GGGGM

för 3 månader sedan

Thank God for this stock today

$CAPR to the rescue, thank you thus far... NFA

kosen

för 3 månader sedan

This pattern looks exactly like yesterday.

If it completely duplicates yesterday’s pattern, we see 11.5 Today???

kosen

för 3 månader sedan

What do we think

At a loss now, watching a bit

GGGGM

för 3 månader sedan

We going up.. The News is here.. NFA.

$CAPR would soar today as the long awaited news is finally here. The FDA accepted a major amendment to Capricor's Biologics License Application (BLA) containing 24-month Phase 3 HOPE-3 extension data. Instead of issuing an immediate rejection, the FDA extended the PDUFA target action date to November 22, 2026. I got in early at $8 and waiting to see above 11 and above.. Note that THIS IS NOT A FINANCIAL ADVICE... NFA

SKM2086

för 3 månader sedan

PT - $54

I'm going with a conservative $25-30. We're on the right track now. Definitely close to making permanent moves upwards. https://uk.investing.com/news/stock-market-news/oppenheimer-upgrades-capricor-stock-rating-on-regulatory-update-93CH-4846076

MarkyBoy212

för 3 månader sedan

Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA

Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA nice news guys

Hazlaw1234

för 3 månader sedan

$CAPR feels like one to watch very closely today 👀

The official PDUFA target date is tomorrow, Saturday 22 August, but with that falling on a weekend there’s a very real possibility we hear something from the FDA today instead. As of now there’s been no decision announced, so I’d expect a lot of eyes on CAPR once the US session gets going and especially into after hours. Could be a very important day for the stock. Definitely worth keeping notifications on. NFA

Walsemaj

för 3 månader sedan

Lots of red today across the market

This is going back up

Lookafterthepennies

för 3 månader sedan

Lawsuit

What’s with the rise in news of a lawsuit

Denna sida kan innehålla användargenererat innehåll som Trading 212 inte ansvarar för. Skaffa alltid information på egen hand. Trading 212 är en execution only-tjänst, vilket innebär att Trading 212 inte erbjuder några investeringsråd eller någon portföljförvaltning.

Provisionsfri investering för alla

Köp och sälj Capricor Therapeutics Inc +0,06 $ (0,8 %) och över 13 000 globala aktier och ETF:er

Andra avgifter kan tillkomma. Se våra Villkor och avgifter.

Se våra villkor och avgifter här

phone

Köp aktier direkt

Välj ditt favoritföretag

Välj hur mycket du vill investera

Få dina aktier på några sekunder

Att bygga förmögenhet är en vana.
Automatisera det med ett pie.

Investera i färdiga pies eller skapa ditt eget genom att välja bland tusentals aktier och ETF

Läs mer

Läs mer

Titta på videon

Förvärva även de dyraste aktierna som Google, Amazon och Apple.

Titta på videon

Se alla handelsinstrument

Support dygnet runt

29 sekunder genomsnittlig svarstid

Börja bygga rikedom nu

Bli en av över 5 miljoner användare

Hämta appen

Öppna konto

Skaffa mobilappen

qr-code

Alla presenterade statistik är global. Antalet kunder representerar finansierade Konto.

Utmärkt

Betyg 4,6 / 5 baserat på 108 764 recensioner av

Trustpilot

Betyg 4,6 / 5 baserat på 108 764 recensioner av

Trustpilot

Inbjuden

Great app very easy to use and lots of…

Great app very easy to use and lots of information. Always upto date with balances and share prices etc.

Inbjuden

Smooth experience

The whole thing is smooth and seamless and makes things easy overall.

Inbjuden

Really easy to use

Really easy to use. Secure and has the best functionality and features.

Inbjuden

Easy to keep up with as informed…

Easy to keep up with as informed everyday or week on interest made . Easy to set up account . No problems .

Inbjuden

Easy to operate and work with

Easy to operate and work with. Works very fast and accurately.

Inbjuden

How you rate the app

This app is so easy to use and safe really love it.

Inbjuden

I opened a cash ISA with them

I opened a cash ISA with them. It was really straightforward to do and interest is added daily. Nice ,easy to use app as well.

Inbjuden

Easy to navigate makes investing…

Easy to navigate makes investing interesting, transferred my investments from HL which was very straightforward and now not paying dealing fee’s Very Happy

Inbjuden

App is easy to work

App is easy to work Good interest rate Daily interest updates

Inbjuden

Very good and informative always stay…

Very good and informative always stay on track with your investments

Inbjuden

Reliable

Reliable, trustworthy app to store your money and to build on your existing wealth if you are financially sensible and smart.

Inbjuden

Great app

Great app. I would recommend to anyone that’s into investing and making their money grow .

Inbjuden

Very easy app to register and use

Very easy app to register and use! Really pleased.

Inbjuden

Clear app

Clear app. Easy to invest. Took a whike for money to get in because i did it from bank rather than in app

Inbjuden

Very smooth and user friendly

Very smooth and user friendly. Have had zero issues having moved from other brokerages. Will keep using.

Inbjuden

Easy to set up and to regular monitor…

Easy to set up and to regular monitor how its performing.

Inbjuden

Competitive rates and quick transfers

Very good on money transfers in and out. They take place immediately unlike some other providers. Very competitive rate on Cash ISA

Inbjuden

Customer support is quick and…

Customer support is quick and effective. The app is well organised and easy to use. Would reccommend for anyone even complete beginners.

Inbjuden

Easy to set up the Cash ISA

Easy to set up the Cash ISA, funds arrived in account almost immediately. Great to see interest accrual amounts daily.

Inbjuden

Reliable

Reliable, Secure. Using it for past 3 years

Visa några av våra positiva kundrecensioner

Våra utmärkelser

Vanliga frågor och svar

Vad är aktiekursen för Capricor Therapeutics?

Det aktuella priset för Capricor Therapeutics är 7,59 $.

Vad är 52‑veckorshögsta för Capricor Therapeutics?

Högsta nivån på 52 veckor för Capricor Therapeutics är 40,37 $.

Vad är 52-veckorslägstanoteringen för Capricor Therapeutics?

Den lägsta nivån på 52 veckor för Capricor Therapeutics är 2,96 $.

Vad är den veckovisa prestandan för Capricor Therapeutics?

Under den senaste veckan har priset på Capricor Therapeutics ändrats med −20,36 %.

Hur ser den månatliga prestationen för Capricor Therapeutics ut?

Under den senaste månaden har priset på Capricor Therapeutics ändrats med 14,14 %.

Vad är 3-månadersprestandan för Capricor Therapeutics?

Under de senaste tre månaderna har priset på Capricor Therapeutics ändrats med −4,89 %.

Hur har 6‑månadersavkastningen för Capricor Therapeutics varit?

Under de senaste sex månaderna har priset på Capricor Therapeutics förändrats med −71,81 %.

Vad är den årliga prestandan för Capricor Therapeutics?

Under det senaste året har priset på Capricor Therapeutics förändrats med 31,54 %.